Table 6.
Run | Surfactant | RA | Diameter size | Drug loading |
---|---|---|---|---|
(mg/mL) | (mg/mL) | (nm ± SD) | (% w/w) | |
HB-1 | — | — | 53 ± 13 | — |
HB-2 | — | 0.5 | 53 ± 16 | 0.94 |
HB-3 | — | 0.3 | 50 ± 20 | — |
HB-4 | 2 | 0.3 | 53 ± 17 | 1.04 |
b% v/v TFE/DMSO.
Run | Surfactant | RA | Diameter size | Drug loading |
---|---|---|---|---|
(mg/mL) | (mg/mL) | (nm ± SD) | (% w/w) | |
HB-1 | — | — | 53 ± 13 | — |
HB-2 | — | 0.5 | 53 ± 16 | 0.94 |
HB-3 | — | 0.3 | 50 ± 20 | — |
HB-4 | 2 | 0.3 | 53 ± 17 | 1.04 |
b% v/v TFE/DMSO.